Metformin may lower the risk for long COVID at 1 year after SARS-CoV-2 infection in people with overweight or obesity, according to a study published in Clinical Infectious Diseases. People with ...
Twenty years after the introduction of the theory, we revisit what it does—and doesn’t—explain. by Clayton M. Christensen, Michael E. Raynor and Rory McDonald Please enjoy this HBR Classic. Clayton M.
Rakesh Sharma is a writer with 8+ years of experience about the intersection between technology and business. Rakesh is an expert in investing, business, blockchain, and cryptocurrencies. Amilcar has ...